revealed that omentin-1, a novel adipocytokine (86), reduced oxidative stress and inflammatory response to improve the deterioration of DN via downregulating the expression of miR-27a, reducing the binding of miR-27a at the 3’ UTR of NRF2, and significantly increasing NRF2 expression (61). The gene discussed is NFE2L2; the disease is liver dysplastic nodule.